Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2012, Article ID 236154, 4 pages
http://dx.doi.org/10.1155/2012/236154
Case Report

Hypertrophic Cardiomyopathy Mimicking Acute Anterior Myocardial Infarction Associated with Sudden Cardiac Death

Department of Cardiology, Heart Center, Zentralklinik Bad Berka, Robert-Koch-Allee 9, 99437 Bad Berka, Germany

Received 8 March 2012; Revised 10 July 2012; Accepted 24 July 2012

Academic Editor: Hisao Ogawa

Copyright © 2012 Y. Daralammouri et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. J. Maron, “Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy,” Circulation, vol. 121, no. 3, pp. 445–456, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. B. J. Gersh, B. J. Maron, R. O. Bonow et al., “2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines developed in collaboration With the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons,” Journal of the American College of Cardiology, vol. 58, no. 25, pp. 2703–2738, 2011. View at Publisher · View at Google Scholar
  3. B. J. Maron, J. A. Towbin, G. Thiene et al., “Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention,” Circulation, vol. 113, no. 14, pp. 1807–1816, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Alcalai, J. G. Seidman, and C. E. Seidman, “Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics,” Journal of Cardiovascular Electrophysiology, vol. 19, no. 1, pp. 104–110, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Ahmad, J. G. Seidman, and C. E. Seidman, “The genetic basis for cardiac remodeling,” Annual Review of Genomics and Human Genetics, vol. 6, pp. 185–216, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. J. M. Bos, J. A. Towbin, and M. J. Ackerman, “Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy,” Journal of the American College of Cardiology, vol. 54, no. 3, pp. 201–211, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. J. G. Seidman and C. Seidman, “The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms,” Cell, vol. 104, no. 4, pp. 557–567, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. B. J. Maron, M. S. Maron, E. D. Wigle, and E. Braunwald, “The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. From idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy,” Journal of the American College of Cardiology, vol. 54, no. 3, pp. 191–200, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. B. J. Maron, M. S. Maron, G. K. Danielson et al., “American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert consensus documents and the European Society of Cardiology Committee for Practice Guidelines,” Journal of the American College of Cardiology, vol. 42, no. 9, pp. 1687–1713, 2003. View at Google Scholar
  10. B. J. Maron, “Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy,” Circulation, vol. 121, no. 3, pp. 445–456, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. B. J. Maron, “The electrocardiogram as a diagnostic tool for hypertrophic cardiomyopathy: revisited,” Annals of Noninvasive Electrocardiology, vol. 6, no. 4, pp. 277–279, 2001. View at Google Scholar · View at Scopus
  12. C. Prinz, M. Farr, D. Hering, D. Horstkotte, and L. Faber, “The diagnosis and treatment of hypertrophic cardiomyopathy,” Deutsches Ärzteblatt international, vol. 108, no. 13, pp. 209–215, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. R. A. Nishimura and D. R. Holmes Jr., “Hypertrophic obstructive cardiomyopathy,” New England Journal of Medicine, vol. 350, no. 13, pp. 1320–1327, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. M. A. Fifer and G. J. Vlahakes, “Management of symptoms in hypertrophic cardiomyopathy,” Circulation, vol. 117, no. 3, pp. 429–439, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. M. S. Maron, E. Appelbaum, C. J. Harrigan et al., “Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy.,” Circulation, vol. 1, no. 3, pp. 184–191, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Rubinshtein, J. F. Glockner, S. R. Ommen et al., “Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy,” Circulation, vol. 3, no. 1, pp. 51–58, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Barriales Villa, R. Bilbao Quesada, E. Iglesias Río, N. Bayón Meleiro, R. Mantilla González, and M. Penas Lado, “Transient left ventricular apical ballooning without coronary stenoses syndrome: importance of the intraventricular pressure gradient,” Revista Espanola de Cardiologia, vol. 57, no. 1, pp. 85–88, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Luria, M. W. Klutstein, D. Rosenmann, J. Shaheen, S. Sergey, and D. Tzivoni, “Prevalence and significance of left ventricular outflow gradient during dobutamine echocardiography,” European Heart Journal, vol. 20, no. 5, pp. 386–392, 1999. View at Publisher · View at Google Scholar · View at Scopus